Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-48
SponsorAretaieion University Hospital
About this trial
This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections
Eligibility criteria
Qualifiers
adult parturients, American Society of Anesthesiologists (ASA) I-II,
singleton gestation>37 weeks
elective cesarean section
Disqualifiers
American Society of Anesthesiologists (ASA) > III
age < 18 years
singleton gestation <37 weeks
Body Mass Index (BMI) >40 kg/m2
Trial design
Treatments tested in this trial
- Chloroprocaine 1% Injectable Solution
- Ropivacaine 0.75% Injectable Solution
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov